Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02734758 · ClinicalTrials.gov registry record

Markers of Atrial Fibrillation

A clinical trial, sponsored by University of California, Davis.

Completed
Registry status
131
Enrollment target

NCT02734758 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 131 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02734758 has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
131 participants
Enrollment target

Study Summary

This study will evaluate whether a gene marker can improve the identification of atrial fibrillation in patients with ischemic stroke, and evaluate whether the decision to anticoagulate could be improved by a marker of atrial fibrillation.

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2011-08
Est. Completion 2020-10-01

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02734758

The ClinicalTrials.gov registry entry for NCT02734758 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02734758 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02734758 about?

NCT02734758 is a clinical study titled "Markers of Atrial Fibrillation". This study will evaluate whether a gene marker can improve the identification of atrial fibrillation in patients with ischemic stroke, and evaluate whether the decision to anticoagulate could be improved by a marker of atrial fibrillation.

What is the current status of trial NCT02734758?

This trial is currently completed. The enrollment target is 131 participants. The study started on 2011-08. Estimated completion is 2020-10-01.

Who is sponsoring clinical trial NCT02734758?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.